Advances in melanoma senescence and potential clinical application - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pigment Cell & melanoma research Année : 2011

Advances in melanoma senescence and potential clinical application

Advances in melanoma senescence and potential clinical application

Résumé

Normal cells possess a limited proliferative life span, after which they enter a state of irreversible growth arrest, called replicative senescence, which acts as a potent barrier against transformation. Transformed cells have escaped the process of replicative senescence and theoretically can not re-enter senescence. However, recent observations showed that transformed cells, and particularly the melanoma cells, can still undergo oncogene or stress-induced senescence. This senescence state is accompanied by many of the markers associated with replicative senescence, such as flattened shape, increased acidic β-galactosidase activity, characteristic changes in gene expression and growth arrest. Interestingly, in some cancers, senescence induction following chemotherapy has been correlated with a favorable patient outcome. In this review, we gathered recent results describing senescence-like phenotype induction in melanoma cells and discuss why senescence may also be exploited as a therapeutic strategy in melanoma.

Mots clés

Domaines

Cancer
Fichier principal
Vignette du fichier
Bertolotto PCMR 2011.pdf (510.72 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-02530650 , version 1 (07-04-2020)

Identifiants

Citer

Sandy Giuliano, Mickaël Ohanna, Robert Ballotti, Corine Bertolotto. Advances in melanoma senescence and potential clinical application. Pigment Cell & melanoma research, 2011, 24 (2), pp.295-308. ⟨10.1111/j.1755-148X.2010.00820.x⟩. ⟨inserm-02530650⟩
62 Consultations
161 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More